Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.31
-0.05 (-0.60%)
Nov 16, 2026, 4:00 PM EST - Market closed

ARCT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
30.5182.03152.31166.820612.36
Revenue Growth
-68.74%-46.14%-8.69%-19.03%1566.79%29.56%
Cost of Revenue
80.52112.21195.16192.13147.75173.76
Gross Profit
-50-30.18-42.85-25.3358.25-161.4
Selling, General & Admin
44.9746.0852.8252.8746.0741.45
Operating Expenses
44.9746.0852.8252.8746.0741.45
Operating Income
-94.97-76.26-95.67-78.2112.18-202.85
Interest Expense
-0.01-0.01----
Interest & Investment Income
7.0610.115.216.59--
Earnings From Equity Investments
-----0.520.52
Currency Exchange Gain (Loss)
0.380.38-0.47-0.23-0.60.58
Other Non Operating Income (Expenses)
0.29----0.42-1.92
EBT Excluding Unusual Items
-87.25-65.78-80.95-61.8410.64-203.67
Other Unusual Items
---33.95--
Pretax Income
-87.25-65.78-80.95-27.8910.64-203.67
Income Tax Expense
-0--01.841.3-
Net Income
-87.24-65.78-80.94-29.739.35-203.67
Net Income to Common
-87.24-65.78-80.94-29.739.35-203.67
Net Income Growth
------
Shares Outstanding (Basic)
282727272626
Shares Outstanding (Diluted)
282727272726
Shares Change
4.50%1.43%1.40%-1.72%2.95%29.61%
EPS (Basic)
-3.08-2.40-3.00-1.120.35-7.74
EPS (Diluted)
-3.08-2.40-3.00-1.120.35-7.74
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-62.45-74.5-60.4-2124.27-138.45
Free Cash Flow Per Share
-2.20-2.72-2.24-0.790.90-5.26
Gross Margin
-163.87%-36.79%-28.13%-15.19%28.28%-
Operating Margin
-311.24%-92.97%-62.81%-46.89%5.91%-1641.33%
Profit Margin
-285.92%-80.19%-53.14%-17.82%4.54%-1647.98%
Free Cash Flow Margin
-204.66%-90.82%-39.65%-12.59%11.78%-1120.23%
EBITDA
-92.38-73.24-92.13-75.2513.7-201.66
EBITDA Margin
--89.28%-60.48%-45.11%6.65%-
D&A For EBITDA
2.583.033.542.961.531.19
EBIT
-94.97-76.26-95.67-78.2112.18-202.85
EBIT Margin
--92.97%-62.81%-46.89%5.91%-
Effective Tax Rate
----12.17%-
Revenue as Reported
30.5182.03152.31166.820612.36
SEC Filings: 10-K · 10-Q